EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrated transcriptomics reveals a TNFRSF-metabolism axis and a context-dependent BCMA signaling state in myeloma progression

Wei-Han Huang, Mohammed Thangameeran Shaik Ismail, Chih-Wen Peng iD

Annals of Hematology · 24.07.2026 · 105 (11)

DOI: 10.1007/s00277-026-07192-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 24.07.2026. Verfasst von Wei-Han Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology & Oncology, Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan. Hauptthemen laut MEDLINE: B-Cell Maturation Antigen, Multiple Myeloma, Signal Transduction, Transcriptome. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Buddhist Tzu Chi Medical Foundation, National Science and Technology Council, National Dong Hwa University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) evolves from monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) with extensive metabolic reprogramming and immune remodeling. We investigated whether coordinated activation of the tumor necrosis factor receptor superfamily (TNFRSF) aligns with metabolic state and prognosis across this continuum. We integrated bone-marrow single-cell RNA sequencing from healthy donors, MGUS, SMM, and MM with bulk RNA sequencing from the Multiple Myeloma Research Foundation (MMRF) CoMMpass cohort. At single-cell resolution, per-cell metabolic activity scores increased with disease stage and were highest in malignant plasma cells. TNF/TNFRSF signaling was strongest in MM, and expression of TNFRSF17 (B-cell maturation antigen, BCMA) in plasma cells correlated with metabolic activity (Spearman ρ = 0.56 in MM). In the clinical cohort, a pooled TNFRSF score stratified overall survival (log-rank p < 0.0001), with individual associations for TNFRSF17 and TNFRSF1A/1B. Joint stratification by TNFRSF activation and metabolic activity revealed the poorest outcomes in tumors with low TNFRSF activation but high metabolic activity, indicating that metabolic state contributes to adverse risk in a receptor-context-dependent manner, while TNFRSF captured additional risk not explained by metabolism alone. When focusing specifically on BCMA, the prognostic ordering across BCMA x metabolism strata was not identical to the pooled TNFRSF model, underscoring that metabolic risk is modulated by the receptor state rather than acting as a universal driver. These findings define an integrated TNFRSF-metabolism axis and a context-dependent BCMA state in advanced MM, clinically relevant but adjustment-sensitive survival associations that warrant further validation and combination strategies that explicitly consider metabolic status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-Cell Maturation AntigenMultiple MyelomaSignal TransductionTranscriptomeReceptors, Tumor Necrosis FactorHumansDisease ProgressionMaleFemaleGene Expression ProfilingReceptors, Tumor Necrosis Factor, Type IGene Expression Regulation, NeoplasticMiddle AgedPrognosis

Stichwörter der Autor:innen

BCMAMetabolic reprogrammingMultiple myelomaSingle-cell transcriptomicsTNF receptor superfamily

Substanzen

B-Cell Maturation AntigenTNFRSF17 protein, humanReceptors, Tumor Necrosis Factor, Type ITNFRSF1A protein, humanReceptors, Tumor Necrosis Factor

Autor:innen und Institutionen

  • Division of Hematology & Oncology, Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
  • Department of Clinical Pathology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
  • School of Medicine, Tzu Chi University, Hualien, Taiwan.
  • Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.
  • Department of Biochemistry and Molecular Medicine, National Dong Hwa University, Hualien, Taiwan.
  • Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan. pengcw@gms.ndhu.edu.tw.

ORCID-Profile: Chih-Wen Peng

Förderung

  • Buddhist Tzu Chi Medical Foundation
  • National Science and Technology Council
  • National Dong Hwa University

Zitieren

APA

Huang, W. H., Ismail, M. T. S., & Peng, C. W. (2026). Integrated transcriptomics reveals a TNFRSF-metabolism axis and a context-dependent BCMA signaling state in myeloma progression. Annals of Hematology, 105(11). https://doi.org/10.1007/s00277-026-07192-w

Vancouver

Huang WH, Ismail MTS, Peng CW. Integrated transcriptomics reveals a TNFRSF-metabolism axis and a context-dependent BCMA signaling state in myeloma progression. Annals of Hematology. 2026;105(11). doi:10.1007/s00277-026-07192-w

BibTeX
@article{Huang2026,
  author = {Huang, Wei-Han and Ismail, Mohammed Thangameeran Shaik and Peng, Chih-Wen},
  title = {Integrated transcriptomics reveals a TNFRSF-metabolism axis and a context-dependent BCMA signaling state in myeloma progression},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {11},
  doi = {10.1007/s00277-026-07192-w}
}
Kostenlos starten →